TITLE

Long Shot

AUTHOR(S)
Crowley, Michael
PUB. DATE
November 2001
SOURCE
New Republic;11/5/2001, Vol. 225 Issue 19, p16
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Questions why the U.S. government does not have any anthrax vaccine available, in light of anthrax bioterrorist attacks on the U.S. View that there is no vaccine because of political shortsightedness, paranoid conspiracy theories, and bureaucratic sluggishness; Discussion on how scientists and federal officials have been warning that anthrax could be used as a weapon; Interest of former U.S. President Bill Clinton in bioterrorism; Details of BioPort Corp., who failed to manufacture the anthrax vaccine due to red tape.
ACCESSION #
5447512

 

Related Articles

  • NEW ANTHRAX VACCINE SUPPLY LIKELY TO BE DELAYED.  // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, pii 

    Reports on the possible delay in the release of anthrax vaccine manufactured by Bioport in the United States. Reason for the delay; Importance of the vaccine;

  • Spore Wars. MacDonald, Elizabeth; Langreth, Robert // Forbes Global;6/6/2005, Vol. 8 Issue 10, p36 

    Examines the preparedness of the U.S. government to respond to the potential threat posed by bioterrorism. Issues arising from the budget allocated by the government to anti-terrorism Project BioShield in 2004 awarded to biotech firm VaxGen; Efforts of rival firm BioPort in lobbying the...

  • Anthrax Vaccine Demand High But Product Availability Is Low. Jarvis, Lisa // Chemical Market Reporter;10/08/2001, Vol. 260 Issue 13, p10 

    Reports on the tight supply of anthrax vaccine in the United States following the September 11, 2001 terrorist attacks in the United States. Information on the anthrax disease; Major issue stalling efforts to bolster military supplies of the vaccine by the sole supplier, BioPort Corp.; Problems...

  • Why BioPort Got a Shot in the Arm. Maier, Timothy W. // Insight on the News;09/20/99, Vol. 15 Issue 35, p13 

    Discusses the anthrax vaccine introduced by the United States military to its personnel which was created by BioPort Corp. Remarks from Republican Representative Walter Jones, member of the House Armed Services Committee; Information on BioPort; Amount of the advance payment of the Department of...

  • Still a Long Wait for Anthrax Vaccine. Maier, Timothy W. // Insight on the News;11/19/2001, Vol. 17 Issue 43, p18 

    Focuses on the challenges faced by the United States (U.S.) government regarding the availability of anthrax vaccines. Criticisms on the safety issues of the vaccine; Alleged complications which may result following the vaccination; Commendation of the U.S. Department of Defense on the safety...

  • Clinton Orders Human Experiments. Maier, Timothy W. // Insight on the News;11/15/99, Vol. 15 Issue 42, p14 

    Deals with United States President Bill Clinton's executive order (EO) 13139 that requires military personnel to receive experimental anthrax vaccines not approved by the Food and Drug Administration. Number of troops awaiting trial on felony charges; Impact on the military; Comments by...

  • A Biodefense Boondoggle? Hogan, Bill // Mother Jones;Jan/Feb2002, Vol. 27 Issue 1, p17 

    Focuses on the financial support of United States government in producing the multimillion-dollar bioterrorism vaccines by pharmaceutical companies. Advantages and disadvantages of the health plan; Reason for not cutting the contract with BioPort Corp., sole manufacturer of anthrax vaccine;...

  • Government vows to cut thousands of red tape regulations.  // Employers Law;Oct2012, p5 

    The article reports that the British government has pledged to examine around 6,500 regulations in an effort to eradicate red tape.

  • Antidote for Anthrax Becomes Antidote for Upgrades. Maier, Timothy W.; Dettmer, Jamie // Insight on the News;06/05/2000, Vol. 16 Issue 21, p6 

    Reports on the Department of Defense inspector general's (IG) probe on BioPort's misuse of funds to develop antidote for anthrax. Factor that lead to the probe; Findings of IG; Comments from BioPort Corp.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics